Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Chiaki Kawase et al.|Molecular Cancer Therapeutics|2010Cited by 88
Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the OvaryTakeshi Hisamatsu, Tadashi Kimura, Hirohisa Kurachi et al.|Molecular Cancer Therapeutics|2013Cited by 41
Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup studyTamaki Tanaka, Atsushi Hongo, Kazuhiro Takehara et al.|Gynecologic Oncology Reports|2025Cited by 1
#215 Retrospective re-evaluation of platinum-free interval and chemotherapeutic effect against subsequent platinum-containing chemotherapy in recurrent ovarian cancer patients initially treated by chemotherapy with bevacizumabTamaki Tanaka, Atsushi Hongo, Tomoka Usami et al.|International Journal of Gynecological Cancer|2023Cited by 0